Pieris
is a Massachusetts-based biotechnology company that develops and commercializes anticalin-derived drugs for the treatment of cancer and respiratory diseases... Read morePieris
is a Massachusetts-based biotechnology company that develops and commercializes anticalin-derived drugs for the treatment of cancer and respiratory diseases... Read more
2001
PublicMerger Pending with Palvella TherapeuticsNASDAQPVLA
News
Apr 09, 2025
Investing.com
Pieris: Pieris Pharmaceuticals Inc receives Investment Bank Analyst Rating Update By Investing.com
Dec 16, 2024
Citybizlist
Pieris: Palvella Therapeutics Closes Merger with Pieris Pharmaceuticals
Dec 16, 2024
The Business Journals: Philadelphia
Pieris: Main Line biotech firm completes reverse merger, raises $78.9 million
Nov 13, 2024
Yahoo
Pieris: Pieris Pharmaceuticals: Q3 Earnings Snapshot
Aug 13, 2024
Benzinga
Pieris: SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Pieris Pharmaceuticals, Inc. - PIRS
Jul 26, 2024
BioCentury
Pieris: Public Equity Report: Palvella lands on NASDAQ via Pieris merger
Jul 24, 2024
Seeking Alpha
Pieris: Pieris Pharma surges on all-stock merger deal
Jul 24, 2024
MarketScreener
Pieris: Shareholder Alert: Ademi LLP investigates whether Pieris Pharmaceuticals, Inc. has obtained a Fair Price for its Public Shareholders
Jul 05, 2024
The Pharma Letter
Pieris: Servier deals blow to Pieris as oncology collab comes to end
May 15, 2024
Owler
Pieris Pharmaceuticals, Inc.: Pieris's revenue changed from $42.81M in Dec 2023 to $40.87M in Mar 2024
Pieris Competitors
1
2
3
4
5
6
7
8
9
10